4
Changes in Ownership
Outset Medical, Inc. Filed Acc 0001484612-23-000032
Chair and CEO sold 40,000 shares at an average $20.00 ($800,180)
- Chair and CEO acquired 40,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Trigg Leslie · Chair and CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +20,000 | $4.11 | $82,200 | 432,451 | D |
| 2023-05-03 | Sale : show line 2 in the form 10b5-1 | −20,000 | $20.01 | $400,180 | 412,451 | D |
| 2023-05-03 | Exercise or conversion : show line 3 in the form 10b5-1 | +9,492 | $4.11 | $39,012 | 421,943 | D |
| 2023-05-03 | Sale : show line 4 in the form 10b5-1 | −9,492 | $20.00 | $189,840 | 412,451 | D |
| 2023-05-03 | Exercise or conversion : show line 5 in the form 10b5-1 | +10,508 | $3.88 | $40,771 | 422,959 | D |
| 2023-05-03 | Sale : show line 6 in the form 10b5-1 | −10,508 | $20.00 | $210,160 | 412,451 | D |
| Open-market sales · 40,000 sh · avg $20.00 · $800,180 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-05-03 | Exercise or conversion : show line 7 in the form 10b5-1 Performance Options (right to buy) | −10,508 | 0 | D |
| 2023-05-03 | Exercise or conversion : show line 8 in the form 10b5-1 Performance Options (right to buy) | −20,000 | 94,910 | D |
| 2023-05-03 | Exercise or conversion : show line 9 in the form 10b5-1 Performance Options (right to buy) | −9,492 | 85,418 | D |
Loading xslF345X04/edgardoc.xml…